Genmab — Februar 2019
-
for the library: Mechanism of Action and Novel IMiD-Based Compounds
and Combinations in Multiple Myeloma https://sci-hub.tw/10.1097/ppo.0000000000000354 -
Are 4-Drug Regimens Here to Stay? Role in Induction
and Salvage Therapies https://sci-hub.tw/10.1097/ppo.0000000000000351 -
I forbindelse med patentsnakken for lidt siden: Ser lige at Celgene også har patent på Thalidomid, som udløber i 2023 i US og 2019 i Europa. Det kan jo undre, da Thalidomid er et tudsegammelt oprindeligt tysk stof. Hvem husker ikke skandalen i 50'erne. Men Celgene har åbenbart lavet en så anderledes ny formulering, at de har kunnet opnå ny patent. https://www.sec.gov/Archives/edgar/data/816284/000095012310055985/filename1.htm
-
så skal du vist ud og finde nogle købere. Det er igen igen en sørgelig volumen
-
more like, short one get one free
-
I was just thinking about financing of the Carlsberg
-
I forlængelse af vores pipeline diskussion i går, hvis pipeline tillægges negativ værdi nu, hvordan ville kursen så reagere på en dårlig nyhed, hvor man stopper et studie grundet diskvalificerende data. I så fald ville den vel stige. Så risikoen lige nu, drejer sig kun om lavere end forventet niveauet af Dara salg. Alt andet rammer vel så positivt.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind